INKON Life Technology Co Ltd - Asset Resilience Ratio
INKON Life Technology Co Ltd (300143) has an Asset Resilience Ratio of 5.73% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 300143 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how INKON Life Technology Co Ltd's Asset Resilience Ratio has changed over time. See 300143 equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down INKON Life Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INKON Life Technology Co Ltd (300143) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥239.00 Million | 5.73% |
| Total Liquid Assets | CN¥239.00 Million | 5.73% |
Asset Resilience Insights
- Limited Liquidity: INKON Life Technology Co Ltd maintains only 5.73% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
INKON Life Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare INKON Life Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for INKON Life Technology Co Ltd (2016–2025)
The table below shows the annual Asset Resilience Ratio data for INKON Life Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.75% | CN¥199.00 Million ≈ $29.12 Million |
CN¥4.19 Billion ≈ $613.51 Million |
+3.90pp |
| 2024-12-31 | 0.85% | CN¥30.00 Million ≈ $4.39 Million |
CN¥3.54 Billion ≈ $517.54 Million |
-10.47pp |
| 2020-12-31 | 11.32% | CN¥300.14 Million ≈ $43.92 Million |
CN¥2.65 Billion ≈ $387.89 Million |
+10.96pp |
| 2018-12-31 | 0.36% | CN¥9.43 Million ≈ $1.38 Million |
CN¥2.62 Billion ≈ $383.74 Million |
+0.12pp |
| 2017-12-31 | 0.24% | CN¥6.22 Million ≈ $909.92K |
CN¥2.61 Billion ≈ $382.08 Million |
-19.49pp |
| 2016-12-31 | 19.73% | CN¥500.00 Million ≈ $73.17 Million |
CN¥2.53 Billion ≈ $370.79 Million |
-- |
About INKON Life Technology Co Ltd
INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was … Read more